One of its core cancer-promoting mechanisms is to activate the PI3K/AKT signaling pathway: SLFN11 knockdown inhibits the phosphorylation of this pathway, and this effect can be reversed by the PI3K activator 740Y-P (19). This evidence concerns the gene SLFN11 and cancer.